Biopharmaceutical Contract Manufacturing Is Becoming a Strategic Growth Engine
This is creating significant opportunities in the biopharmaceutical contract manufacturing market, spanning drug substance, active pharmaceutical ingredient and drug product manufacturing.
The market is estimated to grow from approximately USD 28.0 billion in 2025 to USD 31.0 billion in 2026 and USD 63.9 billion by 2035, representing a CAGR of approximately 8.3%.
For more information on the Biopharmaceutical Contract Manufacturing Market, visit:
https://www.rootsanalysis.com/....reports/biopharmaceu
Curtir
Comentario
Compartilhar
